Sunmax Biotechnology Co (ROCO:4728) Accounts Payable: NT$14 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4728 Sunmax Biotechnology Co Ltd ROCO:4728
88 GF Score
Price NT$378.00
GF Value NT$343.41
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Sunmax Biotechnology Co Accounts Payable?

Sunmax Biotechnology Co ROCO:4728 -1.31% 88 Accounts Payable is NT$14 Mil as of Mar. 2026. GuruFocus rates ROCO:4728 with a GF Score™ of 88/100 and a GF Value™ of NT$343.41 (Fairly Valued). The stock has 4 warning signs investors should review.

Sunmax Biotechnology Co's Accounts Payable for the quarter that ended in Mar. 2026 was NT$14 Mil.

Sunmax Biotechnology Co's quarterly Accounts Payable declined from Sep. 2025 (NT$9 Mil) to Dec. 2025 (NT$7 Mil) but then increased from Dec. 2025 (NT$7 Mil) to Mar. 2026 (NT$14 Mil).

Sunmax Biotechnology Co's annual Accounts Payable increased from Dec. 2023 (NT$7 Mil) to Dec. 2024 (NT$18 Mil) but then declined from Dec. 2024 (NT$18 Mil) to Dec. 2025 (NT$7 Mil).

Sunmax Biotechnology Co Accounts Payable Related Terms

Sunmax Biotechnology Co Accounts Payable Historical Data

* Premium members only.

The historical data trend for Sunmax Biotechnology Co's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sunmax Biotechnology Co Accounts Payable Chart

Sunmax Biotechnology Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.07 14.53 6.91 18.26 7.25

Sunmax Biotechnology Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.90 18.98 9.17 7.25 14.08
ROCO:4728
88GF Score
Sunmax Biotechnology Co Ltd ROCO:4728
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sunmax Biotechnology Co Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of NT$14 Mil mean?
Sunmax Biotechnology Co (ROCO:4728) has a Accounts Payable of NT$14 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Sunmax Biotechnology Co and its competitors.
Is Sunmax Biotechnology Co's Accounts Payable too high?
Sunmax Biotechnology Co's current Accounts Payable is NT$14 Mil. Overall, Sunmax Biotechnology Co has a GF Score™ of 88/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sunmax Biotechnology Co's Accounts Payable compare to VRTX and REGN?
Sunmax Biotechnology Co's Accounts Payable of NT$14 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Sunmax Biotechnology Co and its competitors. Sunmax Biotechnology Co's current Accounts Payable is NT$14 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunmax Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, Sunmax Biotechnology Co (ROCO:4728) is currently considered Fairly Valued. The stock's GF Value™ is NT$343.41, compared to a current price of NT$378.00 — trading 10.1% above its estimated fair value. The current Accounts Payable is NT$14 Mil. Sunmax Biotechnology Co's overall GF Score™ is 88/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Sunmax Biotechnology Co (ROCO:4728), the current Accounts Payable is NT$14 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sunmax Biotechnology Co (ROCO:4728) Overvalued in 2026?

Based on GuruFocus' analysis, Sunmax Biotechnology Co stock appears to be overvalued. The current stock price of NT$378.00 is trading 10.1% above its estimated GF Value™ of NT$343.41. GuruFocus considers Sunmax Biotechnology Co to be Fairly Valued.

Key valuation signals for ROCO:4728:

  • Accounts Payable: NT$14 Mil
  • GF Value™: NT$343.41 vs. price of NT$378.00 (10.1% above fair value)
  • GF Score™: 88/100 with 4 warning signs

No single metric tells the full story. See the ROCO:4728 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sunmax Biotechnology Co Business Description

Address Huandong Road, New Urban District, 1st Floor, No. 10, Lane 31, Section 1, Tainan Science Industrial Park, Tainan, TWN
Sunmax Biotechnology Co Ltd is a biomedical company in Taiwan. It is engaged in the development, manufacturing, and commercialization of Sunmax medical devices and bio-surgical products. Additionally, it also researches, develops, manufactures and sales biomedical material grade collagen and related products. The company's products include medical products, biomedical materials, and porcine collagen skin care products.
88GF Score

Get the complete analysis for ROCO:4728

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$378.00
Price
NT$343.41
GF Value